Literature DB >> 23714208

p38(MAPK)/p53-Mediated Bax induction contributes to neurons degeneration in rotenone-induced cellular and rat models of Parkinson's disease.

Feng Wu1, Zhong Wang, Jin-Hua Gu, Jian-Bin Ge, Zhong-Qin Liang, Zheng-Hong Qin.   

Abstract

Rotenone is an environmental neurotoxin that induces degeneration of dopaminergic (DA) neurons in substantia nigra pars compacta (SNpc), which ultimately results in parkinsonism, but the molecular mechanisms of selective degeneration of nigral DA neurons are not fully understood. In the present study, we investigated the induction of p38(MAPK)/p53 and Bax in SNpc of Lewis rats after chronic treatment with rotenone and the contribution of Bax to rotenone-induced apoptotic commitment of differentiated PC12 cells. Lewis rats were subcutaneously treated with rotenone (1.5mg/kg) twice a day for 50days and the loss of tyrosine hydroxylase (THase), motor function impairment, and expression of p38(MAPK), P-p38(MAPK), p53, and Bax were assessed. After differentiated PC cells were treated with rotenone (500nM) for 6-36h, protein levels of p38(MAPK) and P-p38(MAPK), p53 nuclear translocation, Bax induction and cell death were measured. The results showed that rotenone administration significantly reduced motor activity and caused a loss of THase immunoreactivity in SNpc of Lewis rats. The degeneration of nigral DA neurons was accompanied by the increases in p38(MAPK), P-p38(MAPK), p53, and Bax protein levels. In cultured PC12 cells, rotenone also induced an upregulation of p38(MAPK), P-p38(MAPK), p53 and Bax. Pharmacological inhibition of p38(MAPK) with SB203580 (25μM) blunted rotenone-induced cell apoptosis. Treatment with SB203580 prevented the p53 nuclear translocation and upregulation of Bax. Inhibition of p53 with pifthrin-alpha or Bax with siRNAs significantly reduced rotenone-induced Bax induction and apoptotic cell death. These results suggest that the p38(MAPK)/p53-dependent induction of Bax contributes to rotenone's neurotoxicity in PD models.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Apoptotic; Bax; Parkinson’s disease; Rotenone; p38(MAPK); p53 Nuclear translocation

Mesh:

Substances:

Year:  2013        PMID: 23714208     DOI: 10.1016/j.neuint.2013.05.006

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  17 in total

Review 1.  Apoptotic cell death regulation in neurons.

Authors:  Emilie Hollville; Selena E Romero; Mohanish Deshmukh
Journal:  FEBS J       Date:  2019-07-12       Impact factor: 5.542

2.  Neurotoxin mechanisms and processes relevant to Parkinson's disease: an update.

Authors:  Juan Segura-Aguilar; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2015-01-29       Impact factor: 3.911

3.  Updates in the pathophysiological mechanisms of Parkinson's disease: Emerging role of bone marrow mesenchymal stem cells.

Authors:  Hanaa H Ahmed; Ahmed M Salem; Hazem M Atta; Emad F Eskandar; Abdel Razik H Farrag; Mohamed A Ghazy; Neveen A Salem; Hadeer A Aglan
Journal:  World J Stem Cells       Date:  2016-03-26       Impact factor: 5.326

4.  β-Ecdysterone Protects SH-SY5Y Cells Against 6-Hydroxydopamine-Induced Apoptosis via Mitochondria-Dependent Mechanism: Involvement of p38(MAPK)-p53 Signaling Pathway.

Authors:  Zhi Pan; Yingcai Niu; Yini Liang; Xiaojie Zhang; Miaoxian Dong
Journal:  Neurotox Res       Date:  2016-05-26       Impact factor: 3.911

5.  Rotenone induction of hydrogen peroxide inhibits mTOR-mediated S6K1 and 4E-BP1/eIF4E pathways, leading to neuronal apoptosis.

Authors:  Qian Zhou; Chunxiao Liu; Wen Liu; Hai Zhang; Ruijie Zhang; Jia Liu; Jinfei Zhang; Chong Xu; Lei Liu; Shile Huang; Long Chen
Journal:  Toxicol Sci       Date:  2014-10-09       Impact factor: 4.849

6.  Toxicological evaluation of a rotenone derivative in rodents for clinical myocardial perfusion imaging.

Authors:  Pasan Fernando; Xuxu Yan; Julia Lockwood; Yin Duan; Lihui Wei; R Glenn Wells; Corinne Bensimon; Wayne M Mullett; Terrence Ruddy
Journal:  Cardiovasc Toxicol       Date:  2014-06       Impact factor: 3.231

7.  Inhibiting purinergic P2X7 receptors with the antagonist brilliant blue G is neuroprotective in an intranigral lipopolysaccharide animal model of Parkinson's disease.

Authors:  Xin-Hong Wang; Xin Xie; Xiao-Guang Luo; Hong Shang; Zhi-Yi He
Journal:  Mol Med Rep       Date:  2016-12-23       Impact factor: 2.952

Review 8.  Tp53 gene mediates distinct dopaminergic neuronal damage in different dopaminergic neurotoxicant models.

Authors:  Tao Lu; Paul Kim; Yu Luo
Journal:  Neural Regen Res       Date:  2017-09       Impact factor: 5.135

Review 9.  p38 MAPK and PI3K/AKT Signalling Cascades inParkinson's Disease.

Authors:  Saurabh Kumar Jha; Niraj Kumar Jha; Rohan Kar; Rashmi K Ambasta; Pravir Kumar
Journal:  Int J Mol Cell Med       Date:  2015

10.  Leucine-Rich Repeat Kinase 2 (LRRK2) phosphorylates p53 and induces p21(WAF1/CIP1) expression.

Authors:  Dong Hwan Ho; Hyejung Kim; Jisun Kim; Hyuna Sim; Hyunjun Ahn; Janghwan Kim; Hyemyung Seo; Kwang Chul Chung; Bum-Joon Park; Ilhong Son; Wongi Seol
Journal:  Mol Brain       Date:  2015-09-18       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.